REXAHN PHARMACEUTICALS, INC. 4/A
4/A · REXAHN PHARMACEUTICALS, INC. · Filed May 4, 2006
Insider Transaction Report
Form 4/AAmended
HOLADAY JOHN W DR
Director
Transactions
- Disposition to Issuer
Stock option (right to buy)
2006-05-02−125,000→ 0 totalExercise: $0.80Exp: 2014-04-20→ Common stock (125,000 underlying) - Award
Stock option (right to buy)
2006-05-02+125,000→ 125,000 totalExercise: $0.80Exp: 2014-04-20→ Common stock (125,000 underlying) - Award
Stock option (right to buy)
2006-05-02+70,000→ 70,000 totalExercise: $0.80Exp: 2013-08-05→ Common stock (70,000 underlying) - Disposition to Issuer
Stock option (right to buy)
2006-05-02−70,000→ 0 totalExercise: $0.80Exp: 2013-08-05→ Common stock (70,000 underlying) - Award
Stock option (right to buy)
2006-05-02+20,000→ 20,000 totalExercise: $3.00Exp: 2015-09-12→ Common stock (20,000 underlying) - Disposition to Issuer
Stock option (right to buy)
2006-05-02−20,000→ 0 totalExercise: $3.00Exp: 2015-09-12→ Common stock (20,000 underlying)
Footnotes (3)
- [F1]Pursuant to an agreement dated May 2, 2006, all of Dr. Holaday's options vest and become exercisable immediately upon his termination of service as director of Rexahn Pharmaceuticals, Inc. and may be exercised until 10 years after the original date of grant.
- [F2]Original Form 4 reported 05/02/2016 as the Date Exercisable due to clerical error.
- [F3]The transaction involved an amendment of outstanding options to accelerate vesting and extend the exercise period pursuant to an agreement dated May 2, 2006, resulting in the deemed cancellation of the original options and the grant of replacement options with the same vesting and exercisability terms as the cancelled options.